Selection forces and constraints on retroviral sequence variation

Science

Volumn 292, Issue 5519, 2001, Pages 1106-1109

  Overbaugh, Julie ^a   Bangham, Charles R M ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYMES; IMMUNOLOGY; MUTAGENESIS;

RETROVIRUSES; SEQUENCE VARIATIONS;

ONCOGENIC VIRUSES;

FELINE LEUKEMIA VIRUS; GENE SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS; IMMUNE RESPONSE; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; SEQUENCE ANALYSIS; SIMIAN IMMUNODEFICIENCY VIRUS; TARGET CELL; VIRAL GENETICS; VIRUS TRANSMISSION;

ANIMALS; EVOLUTION; HIV; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA VIRUS, FELINE; MUTATION; RETROVIRIDAE; RETROVIRIDAE INFECTIONS; SELECTION (GENETICS); SIMIAN IMMUNODEFICIENCY VIRUS; VARIATION (GENETICS); VIRAL VACCINES;

FELIDAE; FELINE LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0035844057     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1059128     Document Type: Review

References (43)

1. X. Wei et al., Nature 373, 117 (1995).
2. D. D. Ho et al., Nature 373, 123 (1995).
3. M. Nei, T. Gojobori, Mol. Biol. Evol. 3, 418 (1986).
4. L. M. Mansky, J. Virol. 74, 9525 (2000).
5. J. L. Rohn, J. Overbaugh, in Persistent Viral Infections, J. S. Y. Chen, R. Ahmed, Eds. (Wiley, Chichester, UK, 1999), pp. 379-408.
6. M. M. Anderson et al., Science 287, 1828 (2000).
7. O. Jarrett, P. H. Russell, Int. J. Cancer 21, 466 (1978).
8. P. R. Donahue et al., J. Virol. 62, 722 (1988).
9. J. Overbaugh et al., Science 239, 906 (1988).
10. H. M. Temin, Trends Genet. 7, 71 (1991).
11. J. Overbaugh et al., Nature 332, 731 (1988).
12. Y. Takeuchi et al., J. Virol. 66, 1219 (1992).
13. M. van Zeijl et al., Proc. Natl. Acad. Sci. U.S.A. 91, 1168 (1994).
14. D. G. Miller et al., Proc. Natl. Acad. Sci. U.S.A. 91, 78 (1994).
15. M. P. Kavanaugh et al., Proc. Natl. Acad. Sci. U.S.A. 91, 7071 (1994).
16. F. L. Cosset et al., J. Virol. 69, 6314 (1995).
17. Y. Ina, T. Gojobori, J. Mol. Evol. 31, 493 (1990).
18. S. Niewiesk et al., J. Virol. 68, 6778 (1994).
19. J. P. Slattery et al., Genome Res. 9, 525 (1999).
20. T. Uchiyama, Annu. Rev. Immunol. 15, 15 (1997).
21. M. Nagai et al., J. Neurovirol. 4, 586 (1998).
22. M. Cavrois et al., Oncogene 12, 2419 (1996).
23. G. P. Taylor et al., J. Virol. 73, 10289 (1999).
24. E. Hanon et al., Blood 95, 1386 (2000).
25. C. R. M. Bangham, Curr. Opin. Immunol. 12, 397 (2000).
26. M. Kannagi et al., Int. Immunol. 3, 761 (1991).
27. S. Niewiesk et al., J. Virol. 69, 2649 (1995).
28. R. M. Zinkernagel, H. Hengartner, Immunol. Today 18, 258 (1997).
29. R. M. Bush et al., Science 286, 1921 (1999).
30. B. Korber et al., in The Changing Face of HIV and AIDS, R. Weiss et al., Eds. (Oxford Univ. Press, Oxford, in press).
31. D. Price et al., Proc. Natl. Acad. Sci. U.S.A. 94, 1890 (1997).
32. P. Borrow et al., Nature Med. 3, 205 (1997).
33. J. T. Kimata et al., Nature Med. 5, 535 (1999).
34. E. L. Delwart et al., J. Virol. 68, 6672 (1994).
35. S. M. Wolinsky et al., Science 272, 537 (1996).
36. V. Lukashov et al., J. Virol. 69, 6911 (1995).
37. T. L. Hoffman, R. W. Doms, AIDS 12, S17 (1998).
38. R. Liu et al., Cell 86, 367 (1996).
39. M. Samson et al., Nature 382, 722 (1996).
40. A. McKnight et al., J. Virol. 69, 3167 (1995).
41. E. A. Hoover et al., J. Am. Vet. Med. Assoc. 199, 1392 (1991).
42. M. A. Nowak, R. M. May, Virus Dynamics (Oxford Univ. Press, New York, 2000).
43. J.O. is an Elizabeth Glaser Scientist. We thank M. Emerman, Q. Sattentau, J. Weber, and M. McClure for comments on the manuscript.